TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 97 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q1 2015. The put-call ratio across all filers is 0.54 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $243,000 | -81.8% | 2,200 | -76.8% | 0.00% | -100.0% |
| Q1 2015 | $1,336,000 | -69.8% | 9,474 | -68.3% | 0.00% | -75.0% |
| Q4 2014 | $4,428,000 | -17.6% | 29,881 | -14.5% | 0.00% | -20.0% |
| Q3 2014 | $5,375,000 | -32.5% | 34,937 | -38.5% | 0.01% | -28.6% |
| Q2 2014 | $7,966,000 | +367.5% | 56,806 | +270.0% | 0.01% | +250.0% |
| Q1 2014 | $1,704,000 | +63.1% | 15,351 | +45.3% | 0.00% | +100.0% |
| Q4 2013 | $1,045,000 | +30.1% | 10,563 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $803,000 | – | 10,563 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL LP | 1,104,068 | $104,886,000 | 77.66% |
| Greywolf Capital Management LP | 472,135 | $46,694,000 | 10.17% |
| Consonance Capital Management LP | 263,732 | $26,083,000 | 4.28% |
| Moab Capital Partners | 83,132 | $8,222,000 | 3.77% |
| Raging Capital Management, LLC | 190,151 | $18,806,000 | 3.45% |
| Valentine Capital Asset Management, Inc. | 145,053 | $14,346,000 | 3.07% |
| Assured Investment Management LLC | 1,353,342 | $133,846,000 | 1.21% |
| Ativo Capital Management LLC | 22,828 | $2,258,000 | 0.99% |
| Perceptive Advisors | 56,602 | $5,598,000 | 0.67% |
| Jaffetilchin Investment Partners, LLC | 7,721 | $764,000 | 0.38% |